Met Life Investment Management, LLC Evolus, Inc. Transaction History

Met Life Investment Management, LLC

$18 Billion
Q4 2024

A detailed history of Met Life Investment Management, LLC transactions in Evolus, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 34,272 shares of EOLS stock, worth $500,028. This represents 0.0% of its overall portfolio holdings.

Number of Shares

34,272

Previous 32,228 6.34%

Holding current value

$500,028

Previous $522,000 27.59%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$10.84 - $17.45 $22,156 - $35,667	2,044 Added 6.34%	34,272 $378,000
Q2 2024 Aug 13, 2024	BUY	$10.45 - $13.76 $121,240 - $159,643	11,602 Added 56.25%	32,228 $349,000
Q1 2024 May 14, 2024	BUY	$9.99 - $14.91 $206,053 - $307,533	20,626 New	20,626 $288,000
Q2 2023 Apr 29, 2024	BUY	$7.23 - $10.52 $141,809 - $206,339	19,614 New	19,614 $142,000
Q1 2023 May 09, 2024	BUY	$7.81 - $11.05 $153,185 - $216,734	19,614 New	19,614 $166 Million
Q1 2022 May 10, 2024	BUY	$5.22 - $11.78 $102,385 - $231,052	19,614 New	19,614 $220,000
Q1 2022 Mar 22, 2023	BUY	$5.22 - $11.78 $87,816 - $198,174	16,823 Added 602.76%	19,614 $220,000
Q1 2022 May 12, 2022	BUY	$5.22 - $11.78 $102,385 - $231,052	19,614 New	19,614 $220,000
Q4 2021 Feb 15, 2022	SELL	$5.37 - $8.38 $14,987 - $23,388	-2,791 Closed	0 $0
Q3 2021 May 17, 2024	SELL	$7.36 - $13.67 $74,704 - $138,750	-10,150 Reduced 78.43%	2,791 $21,000
Q3 2021 Jun 21, 2023	SELL	$7.36 - $13.67 $123,817 - $229,970	-16,823 Reduced 85.77%	2,791 $21,000
Q3 2021 Mar 22, 2023	SELL	$7.36 - $13.67 $74,704 - $138,750	-10,150 Reduced 78.43%	2,791 $21,000
Q3 2021 Nov 15, 2021	SELL	$7.36 - $13.67 $74,704 - $138,750	-10,150 Reduced 78.43%	2,791 $21,000
Q2 2021 May 17, 2024	SELL	$8.42 - $13.96 $64,707 - $107,282	-7,685 Reduced 37.26%	12,941 $163,000
Q2 2021 Jun 21, 2023	SELL	$8.42 - $13.96 $56,186 - $93,155	-6,673 Reduced 34.02%	12,941 $163,000
Q2 2021 Mar 22, 2023	BUY	$8.42 - $13.96 $42,445 - $70,372	5,041 Added 63.81%	12,941 $163,000
Q2 2021 Aug 16, 2021	BUY	$8.42 - $13.96 $108,963 - $180,656	12,941 New	12,941 $164,000
Q4 2019 Feb 14, 2020	SELL	$11.58 - $17.37 $91,482 - $137,223	-7,900 Closed	0 $0
Q3 2019 Jul 12, 2023	SELL	$13.91 - $19.87 $162,941 - $232,757	-11,714 Reduced 59.72%	7,900 $123,000
Q3 2019 Mar 22, 2023	BUY	$13.91 - $19.87 $38,836 - $55,477	2,792 Added 54.66%	7,900 $123,000
Q3 2019 Nov 14, 2019	BUY	$13.91 - $19.87 $109,889 - $156,973	7,900 New	7,900 $123,000
Q2 2019 Jul 12, 2023	SELL	$13.19 - $28.36 $191,334 - $411,390	-14,506 Reduced 73.96%	5,108 $74.7 Million
Q2 2019 Aug 14, 2019	SELL	$13.19 - $28.36 $67,374 - $144,862	-5,108 Closed	0 $0
Q1 2019 Jul 13, 2023	SELL	$12.43 - $28.91 $180,309 - $419,368	-14,506 Reduced 73.96%	5,108 $115,000
Q1 2019 Mar 22, 2023	SELL	$12.43 - $28.91 $180,309 - $419,368	-14,506 Reduced 73.96%	5,108 $115,000
Q1 2019 May 15, 2019	BUY	$12.43 - $28.91 $63,492 - $147,672	5,108 New	5,108 $115,000

Others Institutions Holding EOLS

# of Institutions

169

Shares Held

48.8M

Call Options Held

57.2K

Put Options Held

5.5K

View Full List

About Evolus, Inc.

Ticker EOLS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 56,094,800
Market Cap $818M
Description
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...

More about EOLS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Account

Met Life Investment Management, LLC Evolus, Inc. Transaction History